CLINICAL_TRIALS ClinicalTrials.gov record update

Bedside Testing of the CYP2C19 Gene to Asses Effectiveness of Clopidogrel in Coronary Artery Disease Patients Treated With Percutaneous Coronary Intervention : Individualized Antiplatelet Drugs Treatment to Improve Prognosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01823185
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:01.255411+00:00
Published At: 2016-01-22T00:00:00+00:00
Record Updated At: 2016-01-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Coronary Artery Disease", "Myocardial Infarction", "Heart Disease", "Vascular Disease", "Angina Pectoris", "Cardiovascular Disease", "Ischemia", "Infarction", "Embolism", "Thrombosis", "Chest Pain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-01-22"
protocolSection.identificationModule.nctId: "NCT01823185"
protocolSection.identificationModule.officialTitle: "Bedside Testing of the CYP2C19 Gene to Asses Effectiveness of Clopidogrel in Coronary Artery Disease Patients Treated With Percutaneous Coronary Intervention : Individualized Antiplatelet Drugs Treatment to Improve Prognosis"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.